Shots: Shots: Florio GmbH has launched Florio, a digital medical device designed to improve the quality of life for people with hemophilia Florio consist of smartphone app combined with a wearable device and a web-based dashboard for physicians and allow patients to track, monitor and share data related to health in real-time with their health […]Read More
Shots: Enzyre to receive funding to advance its existing technology for the development of the diagnostic device, allowing hemophilia patients to automatically determine their coagulation status at home and transfer test results to HCPs via app The focus of the collaboration is to deliver patient-centric, personalized healthcare to patients and to advance SOC of patients […]Read More
Shots: Sanofi acquires Bioverativ, in all stock transaction with its Eloctate & Alprolix products. Bioverativ to receive $105/share in cash for a premium of 64 % with total deal value as $11.6B The focus of the agreement is to combine Bioverativ’s expertise with its platform for the advancement of fitusiran to treat Hemophilia A and […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
